Clinical Trial Update: Drug Use Surveillance for Brentuximab Vedotin Intravenous Infusion "Untreated CD30-Positive Hodgkin's Lymphoma"

View source ↗

Summary

A clinical trial update reports completion and posting of results for a drug use surveillance study of Brentuximab vedotin in untreated CD30-positive Hodgkin ly…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hodgkin Lymphoma

Drugs mentioned

• Adcetris (Brentuximab vedotin)

Snippet

Sponsor: Takeda | Conditions: Untreated CD30-Positive Hodgkin's Lymphoma | Status: COMPLETED | Results posted: 2024-08-21